I don’t see how GDP growth and Govt debt will influence this stock - at all. Govts, health insurers and even the general public will pay hand over fist for cheap cancer detection and/or prevention.
What is the alternative? - Governments disregard these simple, cheap tests and then subsidise absurd amounts on surgeries, hospital care and deaths when bowel cancer patients expand exponentially? That doesn’t wash financially or from a public health perspective.
Cheap/efficient/accurate tests for life threatening diseases will always be in huge demand, especially with a global market and an ageing population.
Ann: Investor Presentation - December 2020, page-4
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.65M | |||
| Open | High | Low | Value | Volume |
| 6.9¢ | 7.1¢ | 6.9¢ | $10.18K | 143.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 150000 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 134686 | 3 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.1¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 7.1¢ | 7.1¢ | 6.9¢ | 44864 | ||
| Last updated 15.59pm 03/06/2024 ? | |||||
| RHY (ASX) Chart |